Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)
Price and Volume
Detailed Quote| Volume | 315 |
| Open | 54.87 |
| Bid (Size) | 54.00 (300) |
| Ask (Size) | 55.99 (1,300) |
| Prev. Close | 54.87 |
| Today's Range | 54.87 - 54.87 |
| 52wk Range | 34.08 - 56.50 |
| Shares Outstanding | 388,132,400 |
| Dividend Yield | 1.71% |
Top News
More News
Performance
More News
Read More
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript ↗
May 06, 2026
Royalty Pharma reports first quarter 2026 results
May 06, 2026
3 Unpopular Stocks We’re Skeptical Of
April 22, 2026
Royalty Pharma Declares Second Quarter 2026 Dividend
April 17, 2026
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings?
March 25, 2026
Frequently Asked Questions
Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 54.87
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 06/12/26 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 21.30B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.